Despite pricing pressures and the release of mixed clinical data, the Asia Pacific interventional oncology device market will expand rapidly through 2027, driven by the continued growth of cancer incidence, improving access to treatment, and the entry of new foreign and domestic competitors.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the Asia Pacific region across a 10-year period.


Physicians in the Asia Pacific region are looking for various minimally invasive interventional oncology devices to treat liver, kidney, and lung cancers, and many new interventional oncology companies and products are entering the market.

What are the major demographic, economic, and local trend differences across the Asia Pacific region that impact the adoption of and demand for these devices?

How will outcomes of trials like SIRFLOX and FOXFIRE affect the adoption and usage of radioembolization spheres?

What technologies are available, and which products are set to be launched in the different countries going forward?

Reimbursement will be an important factor in the adoption of interventional oncology procedures in the Asia Pacific region.

What is the reimbursement scenario in the different Asia Pacific countries?

How will reimbursement impact the interventional oncology market?

Microwave ablation devices are growing in popularity among interventional oncologists.

What factors are driving the uptake of each of the ablation device types across the Asia Pacific countries?

How does the uptake of microwave ablation devices affect other types of ablation devices, like RF ablation devices, and how are competitors preparing for this shift? 

Adoption of embolization particle technologies such as DEBs will expand through 2027.

What are the drivers that will support the use of DEBs?

How will demographic and economic trends impact the use of these devices?

How will adoption of these devices affect PVA particle and microsphere procedure volumes?

Table of contents

  • Asia Pacific
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Interventional Oncology Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • First-Mover Advantage
        • Mergers, Acquisitions, and Partnerships
        • Clinical Data
        • Product Improvements and Innovations
        • Domestic Competitors
        • Distribution and Sales Network
        • Physician Training and Marketing
      • Market Developments
    • Ablation Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Radiofrequency Ablation Devices
        • Microwave Ablation Devices
        • Cryoablation Devices
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Improvements and Innovations
    • Embolization Particle Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Radioembolization Spheres
        • Drug-Eluting Beads
        • Microspheres
        • PVA Particles
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Nithu Mariya Johnson, PharmD

Nithu Mariya Johnson is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and interventional cardiology device markets. Nithu holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Nithu on twitter: @nithu_22


Related Reports

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe

The European interventional oncology device market will be driven by moderate procedure volume growth, spurred by enhanced cancer detection, rising patient and physician awareness, improved reim...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treat...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European interventional oncology device market will be characterized by procedure volume growth, spurred by enhanced reimbursement, product improvements, and the availability of new technolo...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | United States

The US market for interventional oncology devices continues to grow, driven by expanding treatable patient populations and increasing uptake of premium-priced technology. However, growth in...

View Details